EMD Serono also entered an agreement with the U.S. secretary of commerce to exclude its pharmaceutical products and ingredients from Section 232 tariffs. To further expand therapeutic options for ...

President Donald Trump on Thursday announced that EMD Serono, a Massachusetts-based healthcare company, will lower the price of Gonal-f, a widely used fertility medication, as part of a broader ...

The Trump administration announced that Boston-based drugmaker EMD Serono will lower the price of one of its leading fertility drugs as part of a push to make in vitro fertilization (IVF) more ...

President Trump announced a pair of efforts Thursday aimed at expanding access to in vitro fertilization (IVF) as he seeks to deliver on a major campaign promise. Trump in the Oval Office announced ...

CVS Specialty Pharmacy will be a core partner in the TrumpRx Fertility program. Gonal-F will offer a more competitive price on the TrumpRx platform. Because the program will not launch until 2026, ...

Please provide your email address to receive an email when new articles are posted on . Merck KGaA will lower the costs of its IVF drugs by up to 84%. Patients will be able to purchase the drugs ...

EMD Serono Advances Patient Access to IVF Medicines in the U.S., Aligned with National Health Priorities EMD Serono’s complete fertility medication portfolio, including Gonal‑f®, the most‑prescribed ...

President Donald Trump announced on Thursday that patients will receive discounts for in vitro fertilization (IVF)and fertility treatments. The White House negotiated with EMD Serono, a pharmaceutical ...

President Donald Trump announced a new effort to decrease the cost of in vitro fertilization and other fertility care on Thursday, following through on a campaign promise to help make the procedure ...

BOSTON--(BUSINESS WIRE)--EMD Serono, the Healthcare business of Merck KGaA, Darmstadt, Germany in the U.S. and Canada, in collaboration with President Trump’s administration, announced new patient ...

WOONSOCKET, R.I., Oct. 16, 2025 /PRNewswire/ -- CVS Health (NYSE: CVS) today announced it will support simpler access to more affordable fertility treatments for all Americans through its CVS ...